Opocrin S.p.A. acquires a majority stake in Omikron Italia s.r.l.

Omikron Italia is a Pharmaceutical Company intending to be a partner for Specialists and General Practitioners able to answer in an exhaustive and gradual way to the therapeutic needs of Vascular patients and of those affected by main eye diseases.